We are live on ! Find out more
CCM

Camber Capital Management Portfolio holdings

AUM $1.07B
1-Year Est. Return 8.19%
This Fund
S&P 500
This Quarter Est. Return
-11.77%
1 Year Est. Return
-8.19%
3 Year Est. Return
+26.6%
5 Year Est. Return
+54.57%
10 Year Est. Return
+164.72%
AUM
$1.71B
AUM Growth
+$160M
Cap. Flow
+$357M
Cap. Flow %
20.9%
Top 10 Hldgs %
44.59%
Holding
58
New
13
Increased
12
Reduced
1
Closed
10

Top Buys

Rank Stock Value
1
BHC icon
Bausch Health
BHC
+$148M
2
STJ
St Jude Medical
STJ
+$68.1M
3
ABBV icon
AbbVie
ABBV
+$50.2M
4
ALKS icon
Alkermes
ALKS
+$47.4M
5
BIIB icon
Biogen
BIIB
+$46.2M

Top Sells

Rank Stock Value
1
AZN icon
AstraZeneca
AZN
+$67.9M
2
HCA icon
HCA Healthcare
HCA
+$67.6M
3
MJN
Mead Johnson Nutrition Company
MJN
+$39.5M
4
SUNE
SUNation Energy
SUNE
+$38.9M
5
LH icon
Labcorp
LH
+$37.1M

Sector Composition

Rank Sector Weight
1 Healthcare 68.57%
2 Consumer Staples 0%
3 Technology 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
NVTA
26
DELISTED
Invitae Corporation
NVTA
$28.1M 1.65%
2,746,622
+721,679
+36% +$5.74M
SQNM
27
DELISTED
SEQUENOM INC NEW
SQNM
$24.4M 1.43%
17,325,000
+75,000
+0.4% +$112K
WMGI
28
DELISTED
Wright Medical Group Inc
WMGI
$24.1M 1.41%
+1,452,600
New +$26.9M
OSUR icon
29
OraSure Technologies
OSUR
$279M
$14.5M 0.85%
2,000,000
– –
AMAG
30
DELISTED
AMAG Pharmaceuticals
AMAG
$14M 0.82%
+600,000
New +$14.2M
OPCH icon
31
Option Care Health
OPCH
$3.45B
$13.2M 0.77%
1,545,000
+45,000
+3% +$337K
PLX icon
32
Protalix BioTherapeutics
PLX
$191M
$11.2M 0.65%
1,327,500
– –
ELOS
33
DELISTED
Syneron Medical Ltd
ELOS
$11M 0.64%
1,505,700
– –
DRRX
34
DELISTED
DURECT Corp
DRRX
$8.1M 0.47%
600,000
– –
BIOL
35
DELISTED
Biolase, Inc.
BIOL
$6.99M 0.41%
427
– –
PTCT icon
36
PTC Therapeutics
PTCT
$5.64B
$5.76M 0.34%
893,900
+393,900
+79% +$6.84M
ATXS
37
DELISTED
Astria Therapeutics
ATXS
$5.04M 0.3%
16,667
– –
EPRS
38
DELISTED
EPIRUS BIOPHARMACEUTICALS INC COM
EPRS
$4.97M 0.29%
1,847,500
– –
GNMK
39
DELISTED
GenMark Diagnostics, Inc
GNMK
$3.42M 0.2%
649,097
– –
ANGO icon
40
AngioDynamics
ANGO
$611M
$2.99M 0.18%
243,183
– –
CRDC
41
DELISTED
CARDICA INC COM NEW (DE)
CRDC
$2.98M 0.17%
837,483
-2
-0% -$6
UNIS
42
DELISTED
Unilife Corporation
UNIS
$1.87M 0.11%
275,000
– –
AZN icon
43
AstraZeneca
AZN
$263B
– –
-1,000,000
Closed -$67.9M
BMY icon
44
PUT
Bristol-Myers Squibb
BMY
$133B
– –
-500,000
Closed -$34.4M
HCA icon
45
HCA Healthcare
HCA
$87.2B
– –
-1,000,000
Closed -$67.6M
LH icon
46
Labcorp
LH
$25.4B
– –
-349,200
Closed -$37.1M
SPY icon
47
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$790B
– –
-500,000
Closed -$102M
XLV icon
48
PUT
State Street Health Care Select Sector SPDR ETF
XLV
$41.9B
– –
-16,700
Closed -$1.2M
SUNE
49
SUNation Energy
SUNE
$8.95M
– –
-4
Closed -$38.9M
ARNA
50
DELISTED
Arena Pharmaceuticals Inc
ARNA
– –
-1,050,000
Closed -$19.9M
1
2
3

Similar funds

PP
PrairieView Partners St. Paul, Minnesota $1.03B AUM 11.4% 1-Year Est. Return
SAF
Smith Anglin Financial Dallas, Texas $1.1B AUM 14.08% 1-Year Est. Return
NRD
Nebula Research & Development New York $1.17B AUM 15.19% 1-Year Est. Return
FC
Forte Capital Rochester, New York $930M AUM 24.11% 1-Year Est. Return
GIM
Grassi Investment Management Santa Clara, California $1.26B AUM 23.4% 1-Year Est. Return
SC
Savoie Capital Chicago, Illinois $805M AUM 19.48% 1-Year Est. Return
BWA
Bordeaux Wealth Advisors Menlo Park, California $781M AUM 26.55% 1-Year Est. Return
CCP
Camelot Capital Partners Laguna Beach, California $686M AUM 163.55% 1-Year Est. Return

Camber Capital Management's Q1 2016 Portfolio in Review

As of Q1 2016, Camber Capital Management held 58 positions worth $1.71B, up 10% from $1.55B the previous quarter. Its ten largest holdings account for 45% of the portfolio.

Camber Capital Management deployed $357M of net new capital in Q1 2016, opening 13 new positions and adding to 12 existing holdings. Its largest new stake was Bausch Health: 2,000,000 shares worth $52.6M.

By sector, the portfolio is most concentrated in Healthcare at 69% of assets, up from 65% a quarter earlier, followed by Consumer Staples and Technology.

On the sell side, the largest reduction was CARDICA INC COM NEW (DE), an estimated $6 trimmed.

  • Camber Capital Management's largest Q1 2016 buy was Bausch Health: 2,000,000 shares worth $52.6M.
  • Camber Capital Management added most to Brookdale Senior Living in Q1 2016, an estimated $42M increase.
  • Camber Capital Management's biggest Q1 2016 reduction was CARDICA INC COM NEW (DE), cutting an estimated $6.
  • Camber Capital Management fully exited AstraZeneca in Q1 2016, selling an estimated $67.9M.
  • Camber Capital Management's ten largest holdings make up 45% of its $1.71B portfolio in Q1 2016.
  • Camber Capital Management opened 13 new positions and closed 10 in Q1 2016.
  • Camber Capital Management's portfolio value rose 10% quarter-over-quarter to $1.71B.

Based on Camber Capital Management's 13F filing for Q1 2016, filed 13 May 2016.